FGF21 and metabolic dysfunction-associated steatotic liver disease: found that circulating FGF21 levels in patients with NAFLD/NASH are elevated, and plasma FGF21 is correlated with the severity of steatohepatitis in NASH patients, especially fibrosis (62).